Search Results - Gomez‐Roca, Carlos

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?

    Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas? by Khalifa, Jonathan, Mazieres, Julien, Gomez-Roca, Carlos, Ayyoub, Maha, Moyal, Elizabeth Cohen-Jonathan

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer

    Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer by Leary, Alexandra, Le Tourneau, Christophe, Varga, Andrea, Sablin, Marie-Paule, Gomez-Roca, Carlos, Guilbaud, Nicolas, Petain, Aurelie, Pavlyuk, Mariya, Delord, Jean-Pierre

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending

    Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending by Ortiz Brugués, Ariadna, Sibaud, Vincent, Herbault‐Barrés, Beatrice, Betrian, Sarah, Korakis, Iphigenie, De Bataille, Caroline, Gomez‐Roca, Carlos, Epstein, Joel, Vigarios, Emmanuelle

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer

    Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer by Martin, Nicolas, Isambert, Nicolas, Gomez-Roca, Carlos, Goeldner, Rainer-Georg, Zanetta, Sylvie, Sadrolhefazi, Behbood, de Mont-Serrat, Hélène, Campone, Mario, Delord, Jean-Pierre

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Tumor Growth Rate (TGR) is an early indicator of anti-tumor drug activity in phase I clinical trials

    Tumor Growth Rate (TGR) is an early indicator of anti-tumor drug activity in phase I clinical trials by Ferté, Charles, Fernandez, Marianna, Hollebecque, Antoine, Koscielny, Serge, Levy, Antonin, Massard, Christophe, Balheda, Rastislav, Bot, Brian, Gomez-Roca, Carlos, Dromain, Clarisse, Ammari, Samy, Soria, Jean-Charles

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628 by Stathis, Anastasios, Zucca, Emanuele, Bekradda, Mohamed, Gomez-Roca, Carlos, Delord, Jean-Pierre, de La Motte Rouge, Thibault, Uro-Coste, Emmanuelle, de Braud, Filippo, Pelosi, Giuseppe, French, Christopher A.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer

    Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer by Gomez‐Roca, Carlos, Even, Caroline, Le Tourneau, Christophe, Basté, Neus, Delord, Jean‐Pierre, Sarini, Jerome, Vergez, Sebastien, Temam, Stephane, Hoffmann, Caroline, Rochaix, Philippe, Borcoman, Edith, Gavillet, Bruno, Rouits, Elisabeth, Ménétrey, Annick, Brichory, Franck, Purcea, Daniela, Vuagniaux, Gregoire, Zanna, Claudio

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

    Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia by Vey, Norbert, Delaunay, Jacques, Martinelli, Giovanni, Fiedler, Walter, Raffoux, Emmanuel, Prebet, Thomas, Gomez-Roca, Carlos, Papayannidis, Cristina, Kebenko, Maxim, Paschka, Peter, Christen, Randolph, Guarin, Ernesto, Bröske, Ann-Marie, Baehner, Monika, Brewster, Michael, Walz, Antje-Christine, Michielin, Francesca, Runza, Valeria, Meresse, Valerie, Recher, Christian

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program

    The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program by Aparicio, Thomas, Cozic, Nathalie, de la Fouchardière, Christelle, Meriaux, Emeline, Plaza, Jérome, Mineur, Laurent, Guimbaud, Rosine, Samalin, Emmanuelle, Mary, Florence, Lecomte, Thierry, Gomez-Roca, Carlos, Haineaux, Paul-Arthur, Gratet, Alain, Selves, Jannick, Menu, Yves, Colignon, Nikias, Johnson, Laetitia, Legrand, Frédéric, Vassal, Gilles

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma by O’Neil, Bert H., Wallmark, John M., Lorente, David, Elez, Elena, Raimbourg, Judith, Gomez-Roca, Carlos, Ejadi, Samuel, Piha-Paul, Sarina A., Stein, Mark N., Abdul Razak, Albiruni R., Dotti, Katia, Santoro, Armando, Cohen, Roger B., Gould, Marlena, Saraf, Sanatan, Stein, Karen, Han, Sae-Won

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    From presentation to paper: Gender disparities in oncological research

    From presentation to paper: Gender disparities in oncological research by Dijksterhuis, Willemieke P.M., Stroes, Charlotte I., Tan, Wan‐Ling, Ithimakin, Suthinee, Calles, Antonio, van Oijen, Martijn G.H., Verhoeven, Rob H.A., Barriuso, Jorge, Oosting, Sjoukje F., Ivankovic, Daniela Kolarevic, Furness, Andrew J.S., Bozovic‐Spasojevic, Ivana, Gomez‐Roca, Carlos, van Laarhoven, Hanneke W.M.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients with advanced solid tumours

    A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of AsiDNA, a first-in-class DNA repair inhibitor, administered intravenously in patients w... by Le Tourneau, Christophe, Delord, Jean-Pierre, Kotecki, Nuria, Borcoman, Edith, Gomez-Roca, Carlos, Hescot, Ségolène, Jungels, Christiane, Vincent-Salomon, Anne, Cockenpot, Vincent, Eberst, Lauriane, Molé, Audrey, Jdey, Wael, Bono, Françoise, Trochon-Joseph, Véronique, Toussaint, Hélène, Zandanel, Christelle, Adamiec, Olga, de Beaumont, Olivier, Cassier, Philippe Alexandre

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Phase I Study of the Immunotoxin LMB-100 in Patients with Mesothelioma and Other Solid Tumors Expressing Mesothelin

    Phase I Study of the Immunotoxin LMB-100 in Patients with Mesothelioma and Other Solid Tumors Expressing Mesothelin by Hassan, Raffit, Alewine, Christine, Mian, Idrees, Spreafico, Anna, Siu, Lillian L., Gomez-Roca, Carlos, Delord, Jean-Pierre, Italiano, Antoine, Lassen, Ulrik, Soria, Jean-Charles, Bahleda, Rastilav, Thomas, Anish, Steinberg, Seth M., Peer, Cody J., Figg, William D., Niederfellner, Gerhard, Naegelen, Valérie Méresse, Pastan, Ira

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells

    PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1(hi)CD39(+) CD4 T cells by Balança, Camille-Charlotte, Salvioni, Anna, Scarlata, Clara-Maria, Michelas, Marie, Martinez-Gomez, Carlos, Gomez-Roca, Carlos, Sarradin, Victor, Tosolini, Marie, Valle, Carine, Pont, Frédéric, Ferron, Gwénaël, Gladieff, Laurence, Vergez, Sébastien, Dupret-Bories, Agnès, Mery, Eliane, Rochaix, Philippe, Fournié, Jean-Jacques, Delord, Jean-Pierre, Devaud, Christel, Martinez, Alejandra, Ayyoub, Maha

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

    First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors by Menke-van der Houven van Oordt, C. Willemien, Gomez-Roca, Carlos, van Herpen, Carla, Coveler, Andrew L., Mahalingam, Devalingam, Verheul, Henk M. W., van der Graaf, Winette T. A., Christen, Randolph, Rüttinger, Dominik, Weigand, Stefan, Cannarile, Michael A., Heil, Florian, Brewster, Michael, Walz, Antje-Christine, Nayak, Tapan K., Guarin, Ernesto, Meresse, Valerie, Le Tourneau, Christophe

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients

    Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients by Machiels, Jean-Pascal, Gomez-Roca, Carlos, Michot, Jean-Marie, Zamarin, Dmitriy, Mitchell, Tara, Catala, Gaetan, Eberst, Lauriane, Jacob, Wolfgang, Jegg, Anna-Maria, Cannarile, Michael A, Watson, Carl, Babitzki, Galina, Korski, Konstanty, Klaman, Irina, Teixeira, Priscila, Hoves, Sabine, Ries, Carola, Meneses-Lorente, Georgina, Michielin, Francesca, Christen, Randolph, Rüttinger, Dominik, Weisser, Martin, Delord, Jean-Pierre, Cassier, Philippe

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

    Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simulta... by Laprie, Anne, Ken, Soléakhéna, Filleron, Thomas, Lubrano, Vincent, Vieillevigne, Laure, Tensaouti, Fatima, Catalaa, Isabelle, Boetto, Sergio, Khalifa, Jonathan, Attal, Justine, Peyraga, Guillaume, Gomez-Roca, Carlos, Uro-Coste, Emmanuelle, Noel, Georges, Truc, Gilles, Sunyach, Marie-Pierre, Magné, Nicolas, Charissoux, Marie, Supiot, Stéphane, Bernier, Valérie, Mounier, Muriel, Poublanc, Muriel, Fabre, Amandine, Delord, Jean-Pierre, Cohen-Jonathan Moyal, Elizabeth

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    ACTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)

    ACTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG) by Wen, Patrick, Stein, Alexander, van den Bent, Martin, De Greve, Jacques, Dietrich, Sascha, De Vos, Filip, von Bubnoff, Nikolas, van Linde, Myra, Lai, Albert, Prager, Gerald, Campone, Mario, Fasolo, Angelica, Lopez-Martin, Jose, Min Kim, Tae, Mason, Warren, Hofheinz, Ralf-Dieter, Blay, Jean-Yves, Cho, Daniel, Gazzah, Anas, Gomez-Roca, Carlos, Yachnin, Jeffrey, Boran, Aislyn, Burgess, Paul, Palanichamy, Ilan, Gasal, Eduard, Subbiah, Vivek

    Published 2019
    Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade

    Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade by Gomez-Roca, Carlos, Cassier, Philippe, Zamarin, Dmitriy, Machiels, Jean-Pascal, Luis Perez Gracia, Jose, Stephen Hodi, F, Taus, Alvaro, Martinez Garcia, Maria, Boni, Valentina, Eder, Joseph P, Hafez, Navid, Sullivan, Ryan, Mcdermott, David, Champiat, Stephane, Aspeslagh, Sandrine, Terret, Catherine, Jegg, Anna-Maria, Jacob, Wolfgang, Cannarile, Michael A, Ries, Carola, Korski, Konstanty, Michielin, Francesca, Christen, Randolph, Babitzki, Galina, Watson, Carl, Meneses-Lorente, Georgina, Weisser, Martin, Rüttinger, Dominik, Delord, Jean-Pierre, Marabelle, Aurelien

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

    PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon by Rousseau, Benoit, Bieche, Ivan, Pasmant, Eric, Hamzaoui, Nadim, Leulliot, Nicolas, Michon, Lucas, de Reynies, Aurelien, Attignon, Valerie, Foote, Michael B., Masliah-Planchon, Julien, Svrcek, Magali, Cohen, Romain, Simmet, Victor, Augereau, Paule, Malka, David, Hollebecque, Antoine, Pouessel, Damien, Gomez-Roca, Carlos, Guimbaud, Rosine, Bruyas, Amandine, Guillet, Marielle, Grob, Jean-Jacques, Duluc, Muriel, Cousin, Sophie, de la Fouchardiere, Christelle, Flechon, Aude, Rolland, Frederic, Hiret, Sandrine, Saada-Bouzid, Esma, Bouche, Olivier, Andre, Thierry, Pannier, Diane, El Hajbi, Farid, Oudard, Stephane, Tournigand, Christophe, Soria, Jean-Charles, Champiat, Stephane, Gerber, Drew G., Stephens, Dennis, Lamendola-Essel, Michelle F., Maron, Steven B., Diplas, Bill H., Argiles, Guillem, Krishnan, Asha R., Tabone-Eglinger, Severine, Ferrari, Anthony, Segal, Neil H., Cercek, Andrea, Hoog-Labouret, Natalie, Legrand, Frederic, Simon, Clotilde, Lamrani-Ghaouti, Assia, Diaz, Luis A., Saintigny, Pierre, Chevret, Sylvie, Marabelle, Aurelien

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: